InMed Pharmaceuticals (INM) Change in Acquisitions & Divestments (2019 - 2026)
InMed Pharmaceuticals (INM) reported Change in Acquisitions & Divestments of $16511.0 for Q1 2026, up 2.96% on a YoY basis from $16037.0 in Q1 2025, and up 293.21% quarter-over-quarter from $4199.0 in Q4 2025.
InMed Pharmaceuticals (INM) Change in Acquisitions & Divestments (2019 - 2026) Analysis & Trends
InMed Pharmaceuticals has reported Change in Acquisitions & Divestments for 6 years, with the latest figure at $16511.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Acquisitions & Divestments rose 2.96% year-over-year to $16511.0; the trailing twelve-month figure through Mar 2026 stood at $43898.0 (up 10.83% YoY), and the FY2025 full-year result was $42270.0, changed 0.45% from the prior year.
- Change in Acquisitions & Divestments for Q1 2026 stood at $16511.0, up from $4199.0 in the prior quarter.
- The five-year high for Change in Acquisitions & Divestments was $21324.0 in Q3 2024, with the low at -$431.0 in Q2 2024.
- Historically, Change in Acquisitions & Divestments has averaged $12601.9 across 4 years, with a median of $16274.0 in 2025.
- The largest YoY upside for Change in Acquisitions & Divestments was 617.63% in 2025 against a maximum downside of 24.34% in 2025.
- InMed Pharmaceuticals' Change in Acquisitions & Divestments stood at $21317.0 in 2023, then slumped by 87.44% to $2678.0 in 2024, then soared by 56.8% to $4199.0 in 2025, then soared by 293.21% to $16511.0 in 2026.
- The last three Change in Acquisitions & Divestments figures came in at $16511.0 (Q1 2026), $4199.0 (Q4 2025), and $20957.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | InMed Pharmaceuticals | 6.04 Mn | 796,124.14 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16,511.00 |
| Mar 31, 2026 | 16,511.00 |
| Dec 31, 2025 | 4,199.00 |
| Dec 31, 2025 | 4,199.00 |
| Sep 30, 2025 | 20,957.00 |
| Sep 30, 2025 | 20,957.00 |
| Jun 30, 2025 | 2,231.00 |
| Jun 30, 2025 | 2,231.00 |
| Mar 31, 2025 | 16,037.00 |
| Mar 31, 2025 | 16,037.00 |
| Dec 31, 2024 | 2,678.00 |
| Dec 31, 2024 | 2,678.00 |
| Sep 30, 2024 | 21,324.00 |
| Sep 30, 2024 | 21,324.00 |
| Jun 30, 2024 | -431.00 |
| Jun 30, 2024 | -431.00 |
| Mar 31, 2024 | 21,196.00 |
| Mar 31, 2024 | 21,196.00 |
| Sep 30, 2023 | 21,317.00 |
| Sep 30, 2023 | 21,317.00 |